Quanterix Co. (NASDAQ:QTRX) Short Interest Update

Quanterix Co. (NASDAQ:QTRX) was the target of a large growth in short interest in March. As of March 31st, there was short interest totalling 2,560,000 shares, a growth of 25.5% from the March 15th total of 2,040,000 shares. Based on an average daily volume of 846,400 shares, the days-to-cover ratio is currently 3.0 days. Approximately 7.7% of the company’s stock are sold short.

Quanterix Stock Down 5.0 %

QTRX traded down $0.26 on Monday, reaching $4.89. The company had a trading volume of 519,032 shares, compared to its average volume of 541,735. Quanterix has a 1 year low of $4.67 and a 1 year high of $19.18. The stock has a market capitalization of $189.68 million, a PE ratio of -4.61 and a beta of 1.35. The stock has a 50-day moving average price of $6.80 and a 200-day moving average price of $9.74.

Quanterix (NASDAQ:QTRX) last announced its earnings results on Monday, March 17th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.03). Quanterix had a negative return on equity of 11.74% and a negative net margin of 30.12%. The business had revenue of $35.16 million for the quarter, compared to analysts’ expectations of $34.93 million. As a group, analysts expect that Quanterix will post -0.98 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Quanterix by 2.0% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 520,869 shares of the company’s stock worth $5,537,000 after buying an additional 10,111 shares in the last quarter. Williams Jones Wealth Management LLC. lifted its holdings in Quanterix by 39.9% in the 4th quarter. Williams Jones Wealth Management LLC. now owns 471,514 shares of the company’s stock valued at $5,012,000 after purchasing an additional 134,470 shares in the last quarter. Two Sigma Advisers LP boosted its stake in shares of Quanterix by 35.9% during the 4th quarter. Two Sigma Advisers LP now owns 36,748 shares of the company’s stock worth $391,000 after purchasing an additional 9,700 shares during the last quarter. Two Sigma Investments LP purchased a new stake in shares of Quanterix during the fourth quarter worth about $606,000. Finally, ProShare Advisors LLC acquired a new position in shares of Quanterix in the fourth quarter valued at approximately $108,000. 86.48% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

QTRX has been the topic of several recent analyst reports. Scotiabank reissued an “outperform” rating on shares of Quanterix in a report on Tuesday, March 25th. Canaccord Genuity Group dropped their price objective on Quanterix from $20.00 to $15.00 and set a “buy” rating on the stock in a report on Tuesday, March 18th.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.